In pancreatic cancer, Runx3 expression levels were dependent on Smad4 expression—high Runx3 expression, in the presence of Smad4 inactivation, Kras and p53 oncogenic mutations, correlated with metastatic potential (13). Here, SMAD4 is linked to familial pancreatic carcinoma.